Revenue composition centered on joint development agreements
First written in FY2023-Q1. 10 of 13 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026Addition of revenue from the new businessAnnual report
「Joint development contracts ¥1,050.470 million License contracts - Other - Sales to external customers ¥1,050.470 million Other business (Note) ¥7.289 million Total ¥1,057.759 million」
Joint development contracts remained the main source of revenue, but revenue of ¥7.289 million from the Other Business of the DualPore Solutions Business was added for the first time, broadening the revenue mix to two businesses. - 2026-09-04OtherGeneral Meetings of Shareholders
「Joint development agreements 1,050,470 — 1,050,470 License agreements — — — Other — 7,289 7,289」
売上高の大部分が共同開発契約による構成とライセンス契約収入がない状態は続く一方、その他事業として7,289千円を区分表示している。 - FY2027-H1RestatedAnnual report
「Joint development contracts ¥340.203 million Licensing contracts — Other — Revenue from contracts with customers ¥340.203 million」
All ¥340.203 million in sales for the current interim accounting period came from joint development contracts, and no licensing revenue was recognized. - FY2025RestatedAnnual report
「Joint development contracts ¥1,608.370 million Licensing contracts — Other ¥0.033 million Revenue from contracts with customers ¥1,608.403 million」
Joint development contracts accounted for almost all sales, and licensing revenue continued not to be recognized. - FY2025-H1RestatedAnnual report
「Joint development contracts ¥325.360 million Licensing contracts — Other ¥0.033 million Revenue from contracts with customers ¥325.393 million」
Of the ¥325.393 million in sales for the interim accounting period, joint development contracts accounted for ¥325.360 million, and no licensing revenue was recognized. - FY2024RestatedAnnual report
「Joint development contracts ¥1,863.320 million Licensing contracts — Other —」
All ¥1,863.320 million in sales for the fiscal year came from joint development contracts, and licensing revenue continued not to be recognized. - FY2024-Q3RestatedAnnual report
「Joint development contracts ¥1,270.877 million Licensing contracts — Other —」
All ¥1,270.877 million in sales to external customers for the cumulative third quarter came from joint development contracts, and no licensing contract sales were recognized. - FY2024-Q2RestatedAnnual report
「Joint development contracts ¥238.762 million Licensing contracts — Other —」
All ¥238.762 million in sales to external customers for the cumulative second quarter came from joint development contracts, and no licensing contract sales continued to be recognized. - FY2024-Q1RestatedAnnual report
「Joint development contracts ¥102.655 million Licensing contracts — Other —」
All ¥102.655 million in sales for the cumulative first quarter came from joint development contracts, and no licensing contract sales continued to be recognized. - FY2023RestatedAnnual report
「Joint development contracts ¥1,196.153 million Licensing contracts — Other ¥19.200 million」
Joint development contracts accounted for most of the ¥1,215.353 million in sales for the fiscal year, and no licensing contract sales were recognized. - FY2023-Q3RestatedAnnual report
「Joint development contracts ¥594.678 million Licensing contracts — Other ¥0.300 million」
Joint development contracts accounted for most of the ¥594.978 million in sales for the cumulative third quarter, and no licensing contract sales continued to be recognized. - FY2023-Q2RestatedAnnual report
「Joint development contracts ¥342.384 million Licensing contracts — Other ¥0.300 million」
Joint development contracts accounted for most of the ¥342.684 million in sales for the cumulative second quarter, and no licensing contract sales continued to be recognized. - FY2023-Q1First statedAnnual report
「Joint development contracts ¥157.022 million Licensing contracts — Other ¥0.300 million」
Of the ¥157.322 million in sales to external customers in the first quarter, joint development contracts accounted for ¥157.022 million, and no licensing contract sales were recognized.